Nkarta (NKTX) Accumulated Expenses (2019 - 2026)
Nkarta's (NKTX) quarterly Accumulated Expenses came in at $9.5 million in Q1 2026, down 15.69% year-on-year from $11.3 million in Q1 2025, and down 28.21% quarter-over-quarter from $13.3 million in Q4 2025.
Nkarta (NKTX) Accumulated Expenses (2019 - 2026) Analysis & Trends
Nkarta's Accumulated Expenses history runs 8 years deep, the most recent figure standing at $9.5 million for Q1 2026.
- On a quarterly basis, Accumulated Expenses fell 15.69% year-over-year to $9.5 million in Q1 2026; TTM through Mar 2026 was $9.5 million, a 15.69% decrease from a year earlier, with the FY2025 full-year figure at $13.3 million, up 8.66% from the prior year.
- Accumulated Expenses declined to $9.5 million in Q1 2026 per NKTX's latest filing, from $13.3 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $17.6 million in Q2 2023 and bottomed at $6.3 million in Q1 2022.
- The 5-year median for Accumulated Expenses is $12.2 million (2024), against an average of $12.3 million.
- Across the five-year window, Accumulated Expenses surged 145.67% in 2023 and slumped 34.11% in 2024, its largest moves.
- Year by year, Accumulated Expenses stood at $16.0 million in 2022, then fell by 15.22% to $13.6 million in 2023, then fell by 10.05% to $12.2 million in 2024, then advanced by 8.66% to $13.3 million in 2025, then fell by 28.21% to $9.5 million in 2026.
- Per Business Quant, the three latest NKTX Accumulated Expenses figures stand at $9.5 million (Q1 2026), $13.3 million (Q4 2025), and $11.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.54 Mn |
| Dec 31, 2025 | 13.29 Mn |
| Sep 30, 2025 | 11.18 Mn |
| Jun 30, 2025 | 10.51 Mn |
| Mar 31, 2025 | 11.32 Mn |
| Dec 31, 2024 | 12.23 Mn |
| Sep 30, 2024 | 13.78 Mn |
| Jun 30, 2024 | 11.57 Mn |
| Mar 31, 2024 | 12.93 Mn |
| Dec 31, 2023 | 13.60 Mn |
| Sep 30, 2023 | 15.30 Mn |
| Jun 30, 2023 | 17.55 Mn |
| Mar 31, 2023 | 14.82 Mn |
| Dec 31, 2022 | 16.04 Mn |
| Sep 30, 2022 | 11.57 Mn |
| Jun 30, 2022 | 7.15 Mn |
| Mar 31, 2022 | 6.32 Mn |
| Dec 31, 2021 | 9.35 Mn |
| Sep 30, 2021 | 7.45 Mn |
| Jun 30, 2021 | 5.81 Mn |